Dr. Paul Joyce
speaker
112 appearances
1 recordings
1 series
first heard Jun 2026
last heard 14 Jun
Dr. Paul Joyce’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 1 in all, peaking in Jun 2026 with 1.
Appearances
Yeah, absolutely.
I mean, Ozempic and GLP-1 drugs in general have become household names.
So it was probably about 2021 or 2022 where some of the real clinical data started to come out that
These drugs don't just work for diabetes, but they also work for promoting weight loss.
And so the clinical data suggested that people can lose up to around 15% to 25% of their weight.
But, I mean, it's quite interesting in the sense that it seems like it's only happened in the last few years, but it's actually been, you know, 20 years in the making.
Yeah, absolutely.
And I think, you know, there's more and more evidence coming out kind of every day that these drugs can work across a broad spectrum of diseases.
Yeah.
So what happens is in our bodies, when we consume food, a hormone is produced, it's called GLP-1.
And so what happens is that signals to your brain that you're full.
And so essentially, these drugs are simulating that hormone.
And so they work on certain receptors within your body that then tell your body you're full and tell you to, I guess, stop eating or suppress your appetite.
GLP-1 drugs have been shown to help control addiction and things like alcohol consumption, smoking cigarettes, because it is a chemical messenger that performs more than just telling us to suppress our appetite.
And so these GLP-1 receptors are found all throughout the body.
So they're found in the brain, they're found in your pancreas, in your kidneys.
And so it's not just your stomach that it's affecting.
Exactly.
Yeah, that's right.
Yeah.
Showing 1–20 of 112 · page 1 of 6
Next →